Nutromics
Company

Last deal

$7.4M
Local Amount - AUD 11M

Amount

Seed

Stage

08.06.2023

Date

7

all rounds

$14.5M

Total amount

General

About Company
Nutromics is a MedTech company that revolutionizes healthcare through real-time remote biomarker monitoring devices.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Nutromics develops medical-grade sensor technology that offers wearable sensors and software solutions to continuously monitor biomarkers for diet, sleep, stress, and exercise. Their Smart Patch biosensor platform aims to solve some of the biggest healthcare challenges in chronic disease prevention, management, acute diseases, and Therapeutic Drug Monitoring. Nutromics' DNA-based sensors coated onto the tips of microneedles unlock continuous and real-time monitoring of multiple clinically relevant targets for some of the deadliest disease states in the world. Founded in 2017, Nutromics has raised US$20 million and won several awards, including Technology Platform Solution of the Year at the national iAwards. With teams across Australia and the US, Nutromics aims to create a world with zero preventable deaths due to a lack of continuous diagnostic monitoring.